Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

People In Brief

This article was originally published in The Tan Sheet

Executive Summary

Autor leaves FDA for Mylan; Cleary succeeds Clif Bar founders as CEO; Spahr joins Partnership Capital Growth Advisors; EHPM elects Maggiar chairman; ForeverGreen hires international field director; more People In Brief.

You may also be interested in...



FDA Mines Small Field Of Industry Candidates To Fill Executive Vacancies

Criteria for FDA’s leadership posts are extensive and the hiring process is long, but Richard Moscicki still believes industry and academics should consider applying. As more long-time officials retire, he says it is critical to fill open positions to allow for a “smooth transition over an extended period of time.”

FDA Mines Small Field Of Industry Candidates To Fill Executive Vacancies

Criteria for FDA’s leadership posts are extensive and the hiring process is long, but Richard Moscicki still believes industry and academics should consider applying. As more long-time officials retire, he says it is critical to fill open positions to allow for a “smooth transition over an extended period of time.”

FDA Becomes An Agency Of “Directorates” Under Hamburg’s Reorganization

Commissioner Margaret Hamburg’s structural reorganization of FDA leaves the current leadership of the agency’s centers intact, but adds a new layer of management and accountability between the medical product center directors and the commissioner’s office.

Topics

Related Companies

UsernamePublicRestriction

Register

RS150923

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel